Fragneto R Y, Bader A M, Rosinia F, Arthur G R, Datta S
Department of Anesthesia, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Anesth Analg. 1994 Aug;79(2):295-7. doi: 10.1213/00000539-199408000-00016.
Pregnancy-related anatomic and physiologic changes result in altered pharmacologic and toxicologic responses to local anesthetics. Reductions in serum protein binding have been implicated in enhanced toxic effects. Previous studies have demonstrated these reductions in protein binding only in the term parturient. The present study defines the pattern of protein binding changes of lidocaine throughout gestation. Venous samples were obtained from pregnant patients of varying gestational age, as well as from nonpregnant control patients. The percent free drug at a fixed concentration (2 micrograms/mL) was determined for each sample using an ultrafiltration technique. The free concentration of lidocaine increased significantly throughout gestation, reflecting a corresponding decrease in protein binding. However, these changes were small compared to those in the nonparturient, which suggests that toxicity to lidocaine should not vary during pregnancy.
与妊娠相关的解剖和生理变化会导致对局部麻醉药的药理和毒理反应发生改变。血清蛋白结合率降低与毒性增强有关。先前的研究仅在足月产妇中证实了这些蛋白结合率的降低。本研究确定了利多卡因在整个妊娠期的蛋白结合变化模式。从不同孕周的孕妇以及非孕对照患者中采集静脉样本。使用超滤技术测定每个样本在固定浓度(2微克/毫升)下的游离药物百分比。利多卡因的游离浓度在整个妊娠期显著增加,反映出蛋白结合率相应降低。然而,与非产妇相比,这些变化较小,这表明妊娠期对利多卡因的毒性不应有所不同。